Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margaret K Callahan

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Cancer Journal (Sudbury, Mass.)|April 26, 2016
Immune Checkpoint Therapy in MelanomaMargaret K Callahan
Seminars in Oncology|August 31, 2015
Clinical Activity, Toxicity, Biomarkers, and Future Development of CTLA-4 Checkpoint AntagonistsMargaret K Callahan, Jedd D Wolchok
Cancer Cell|September 19, 2019
Recruit or Reboot? How Does Anti-PD-1 Therapy Change Tumor-Infiltrating Lymphocytes?Margaret K Callahan, Jedd D Wolchok
Cancer Journal (Sudbury, Mass.)|April 21, 2010
Implanted hepatic arterial infusion pumpsMargaret K Callahan, Nancy E Kemeny
Journal of Leukocyte Biology|May 14, 2013
At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapyMargaret K Callahan, Jedd D Wolchok
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2019
Low-Level Inhibition of Hsp90 Forces Cells to Tip Their (Antigenic) HandPramod K Srivastava, Margaret K Callahan
Cancer Journal (Sudbury, Mass.)|September 29, 2011
Beyond cancer vaccines: a reason for future optimism with immunomodulatory therapyMichael Postow, Margaret K Callahan, Jedd D Wolchok
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2008
Heat-shock protein 90 associates with N-terminal extended peptides and is required for direct and indirect antigen presentationMargaret K Callahan, Manish Garg, Pramod K Srivastava
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2004
Resistance to CD4+CD25+ regulatory T cells and TGF-beta in Cbl-b-/- miceElizabeth A Wohlfert, Margaret K Callahan, Robert B Clark
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2012
The antitumor immunity of ipilimumab: (T-cell) memories to last a lifetime?Michael A Postow, Margaret K Callahan, Jedd D Wolchok
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Cancer Journal (Sudbury, Mass.)|April 26, 2016
Immune Checkpoint Therapy in MelanomaMargaret K Callahan
Seminars in Oncology|August 31, 2015
Clinical Activity, Toxicity, Biomarkers, and Future Development of CTLA-4 Checkpoint AntagonistsMargaret K Callahan, Jedd D Wolchok
Cancer Cell|September 19, 2019
Recruit or Reboot? How Does Anti-PD-1 Therapy Change Tumor-Infiltrating Lymphocytes?Margaret K Callahan, Jedd D Wolchok
Cancer Journal (Sudbury, Mass.)|April 21, 2010
Implanted hepatic arterial infusion pumpsMargaret K Callahan, Nancy E Kemeny
Journal of Leukocyte Biology|May 14, 2013
At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapyMargaret K Callahan, Jedd D Wolchok
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2019
Low-Level Inhibition of Hsp90 Forces Cells to Tip Their (Antigenic) HandPramod K Srivastava, Margaret K Callahan
Cancer Journal (Sudbury, Mass.)|September 29, 2011
Beyond cancer vaccines: a reason for future optimism with immunomodulatory therapyMichael Postow, Margaret K Callahan, Jedd D Wolchok
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2008
Heat-shock protein 90 associates with N-terminal extended peptides and is required for direct and indirect antigen presentationMargaret K Callahan, Manish Garg, Pramod K Srivastava
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2004
Resistance to CD4+CD25+ regulatory T cells and TGF-beta in Cbl-b-/- miceElizabeth A Wohlfert, Margaret K Callahan, Robert B Clark
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2012
The antitumor immunity of ipilimumab: (T-cell) memories to last a lifetime?Michael A Postow, Margaret K Callahan, Jedd D Wolchok
Pageof 10